Senior Vice President, Research, Pharmaceutical an
Mark Namchuk leads research, pharmaceutical development, process development and nonclinical development of the company’s early-stage product pipeline at Alkermes. Prior to joining Alkermes in 2015, Dr. Namchuk served as Senior Vice President and Interim Global Head of Research for Vertex Pharmaceuticals, leading a group of more than 450 researchers in the discovery of transformational medicines in the areas of infectious disease, oncology, inflammatory diseases, neurology and cystic fibrosis. In addition, Dr. Namchuk developed the high throughput enzymology paradigm in support of the Vertex Chemogenomics effort and co-chaired the committee responsible for new-target selection and prosecution for the company. Earlier in his career, he served as the head of the biochemistry group at Cubist Pharmaceuticals. Dr. Namchuk obtained his doctorate in bioorganic chemistry from the University of British Columbia and completed a post-doctoral fellowship at the University of California, San Francisco.